StreetAlpha.app
Home › Stocks › GRDN

Guardian Pharmacy Services, Inc. (GRDN)

$50.37
▲ +1.91%
LAST CLOSE · NOV 17

Guardian Pharmacy Services provides pharmacy dispensing and medication management services to residents of long term care facilities. It last closed at $50.37 on Nov 17, up 1.91% on the day. The average 12-month price target from 2 analysts is $51.50 (+2.2% from the last close), with a high of $52.00 and a low of $51.00.

AI Auto Pilots
Is GRDN in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$1.5B
+4.9% vs a year ago
Net income
$74.8M
+85.8% vs a year ago
Gross margin
22.4%
$327.1M gross profit
Operating margin
6.5%
$94.1M operating income
Balance sheet
Cash & equivalents
$119.7M
At Sep 30
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2024: $1.2B$1.2BFY2024FY2025: $1.4B$1.4BFY2025

From GRDN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated GRDN in the past 90 days, not enough for a consensus
Average 12-month target
$51.50
▲ 2.2% upside

Based on 2 analysts who set a price target on GRDN in the past 90 days. The average target is $51.50, with a high of $52.00 and a low of $51.00, compared with the last close of $50.37.

Low $51.00Avg $51.50High $52.00
Blue marker: last close $50.37
Highest target$52.00
Average target$51.50
Lowest target$51.00
Latest rating changes
KeybancInitiated
Sep 23Buy$52
Truist SecuritiesTarget raised
Sep 21Buy$47 → $51
OppenheimerMaintained
Aug 7Buy$49
Truist SecuritiesMaintained
Jun 17Buy$47
B of A SecuritiesTarget raised
Jun 17Buy$42 → $47
DateFirmActionRatingPrice target
Sep 23KeybancInitiatedBuy$52
Sep 21Truist SecuritiesTarget raisedBuy$47 → $51
Aug 7OppenheimerMaintainedBuy$49
Jun 17Truist SecuritiesMaintainedBuy$47
Jun 17B of A SecuritiesTarget raisedBuy$42 → $47
Loading…

Technical Analysis

GRDN · as of the Nov 17 close · updated after every close
Uptrend, overbought

The stock is 14% above its 20 day and 15% above its 50 day average. It is 22% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 73), overbought. The nearest support is the Pivot at $50.12, and the nearest resistance the swing high (Nov 11) at $50.59.

Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityNormal, 3.7%/day
Key levels
$51.05Pivot R1+1.4%
$50.8052 week high+0.9%
$50.59Swing high (Nov 11)+0.4%
$50.37Last close
$50.12Pivot−0.5%
$49.45Pivot S1−1.8%
$43.4420 day average−13.8%
$42.8050 day average−15.0%
$41.33100 day average−17.9%
$40.04Swing low (Oct 1)−20.5%
$39.04200 day average−22.5%
$26.3452 week low−47.7%
Indicators
RSI (14)72.61Overbought above 70Overbought
MACD2.44Above its signal lineBullish
Stochastic92.2Near the top of its rangeOverbought
ADX (14)28.0Trending up
Williams %R-3.8Oversold below −80, overbought above −20Overbought
CCI (20)115.6Oversold below −100, overbought above 100Overbought
Rate of change+23.1%Change over 10 sessionsBullish
ATR (14)$1.86Typical daily range, 3.7% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for GRDN

What happened before

See how GRDN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in GRDN in the last 90 days.

Loading…

See today’s whale options flow across the market →

GRDN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲108 buying vs 83 selling
  • ●Shares held by funds +0.8%
  • ▲Funds holding +8
  • ▼Superinvestors: 0 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding197189+4.2%
In funds' top 1012−50.0%
Held by funds–––
New / increased29 / 7934 / 73+0.9%
Reduced / sold out60 / 2353 / 15+22.1%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See GRDN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GRDN is in one of them and how their past GRDN trades turned out.

GRDN in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered GRDN in an article yet. Here's the latest on the wider market.

About Guardian Pharmacy Services

Guardian Pharmacy Services is a pharmacy services company based in Atlanta, Georgia. It dispenses, packages and delivers prescription medications to residents of long term care facilities, with a focus on assisted living facilities and behavioral health facilities. Its services include compliance packaging, automated robotic dispensing, medication administration training for facility staff and drug regimen reviews. Its customers include the residents, the facilities that house them and health plan payors.

Headquarters
Atlanta, GA